Hofseth Biocare ASA (HOFBC.OL)
22 Oct 2014
|Market Cap (Mil.):||kr294.11|
|Shares Outstanding (Mil.):||98.04|
* Says Hofseth Biocare ASA signs distribution of Salmon Protein Hydrolysate with Aceto Health Ingredients GmbH for the European market
* Completes clinical study on salmon protein, showing strong results on treatment of anemia and obesity
* Says signs LOI (letter of intent) for distribution of Salmon Protein Hydrolysate with Aceto Health Ingredients GmbH
BRIEF-Hofseth Biocare ASA replaces damaged critical part in production and sells more fresh salmon oil
Aug 20 - Hofseth Biocare ASA : * Hofseth Biocare ASA : replaces damaged critical part in production and sells
July 28 - Hofseth Biocare ASA : * Says has received order for fresh salmon oil capsules from a Finnish customer * Says entered into an exclusivity agreement on encapsulated salmon oil to the
Earnings vs. Estimates
Analyst Research Reports
Hofseth Biocare ASA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: Wright Reports
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.